Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study

被引:2
|
作者
Kroloff, Maxwell [1 ,2 ]
Ramezani, Ramin [2 ,3 ]
Wilhalme, Holly [4 ]
Naeim, Arash [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Jonsson Comprehens Canc Ctr, 10911 Weyburn Ave,Suite 300, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Ctr Smart Hlth, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA
关键词
remote monitoring; febrile neutropenia; temperature; heart rate; oxygen saturation; mobile health; mHealth; hematologic malignancies; hematology; malignancies; digital health; clinical outcomes; CANCER;
D O I
10.2196/33265
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Febrile neutropenia is one of the most common oncologic emergencies and is associated with significant, preventable morbidity and mortality. Most patients who experience a febrile neutropenia episode are hospitalized, resulting in significant economic cost. Objective: This exploratory study implemented a remote monitoring system comprising a digital infrared thermometer and a pulse oximeter with the capability to notify providers in real time of abnormalities in vital signs that could suggest early clinical deterioration and thereby improve clinical outcomes. Methods: The remote monitoring system was implemented and compared to standard-of-care vital signs monitoring in hospitalized patients with underlying hematologic malignancies complicated by a febrile neutropenia episode in order to assess the feasibility and validity of the system. Statistical analysis was performed using the intraclass correlation coefficient (ICC) to assess the consistency between the measurements taken using traditional methods and those taken with the remote monitoring system for each of the vital sign parameters (temperature, heart rate, and oxygen saturation). A linear mixed-effects model with a random subject effect was used to estimate the variance components. Bland-Altman plots were created for the parameters to further delineate the direction of any occurring bias. Results: A total of 23 patients were enrolled in the study (mean age 56, SD 23-75 years; male patients: n=11, 47.8%). ICC analysis confirmed the high repeatability and accuracy of the heart rate assessment (ICC=0.856), acting as a supplement to remote temperature assessment. While the sensitivity and specificity for capturing tachycardia above a rate of 100 bpm were excellent (88% and 97%, respectively), the sensitivity of the remote monitoring system in capturing temperatures >37.8 degrees C and oxygen saturation <92% was 45% and 50%, respectively. Conclusions: Overall, this novel approach using temperature, heart rate, and oxygen saturation assessments successfully provided real-time, clinically valuable feedback to providers. While temperature and oxygen saturation assessments lagged in terms of sensitivity compared to a standard in-hospital system, the heart rate assessment provided highly accurate complementary data. As a whole, the system provided additional information that can be applied to a clinically vulnerable population. By transitioning its application to high-risk patients in the outpatient setting, this system can help prevent additional use of health care services through early provider intervention and potentially improve outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] POST CHEMOTHERAPY FEBRILE NEUTROPENIA IN HEMATOLOGIC MALIGNANCIES: CLINICAL CHARACTERISTICS AND OUTCOME
    Syrigou, A.
    Iskas, M.
    Antoniou, A.
    Marvaki, N.
    Baliakas, P.
    Papadopoulos, V.
    Kelaidi, C.
    Lalayanni, C.
    Saloum, R.
    Sotiropoulos, D.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 572 - 573
  • [22] Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies
    Sugahara, H
    Mizuki, M
    Matsumae, S
    Nabetani, Y
    Kikuchi, M
    Kanakura, Y
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (01): : 51 - 54
  • [23] Febrile neutropenia in hematologic malignancies: Validation of a model to select patients manageable in the outpatient setting safely
    Bains, Sarina
    Goy, Andre
    Fuchs, Barry
    Gadaleta, Gabriella
    Singavi, Arun
    Hurtubise, Brenda
    Sebti, Rani
    Feldman, Tatyana
    Goldberg, Stuart
    Pecora, Andrew
    Mato, Anthony R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies
    Mariana, Chumbita
    Olivier, Peyrony
    Christian, Teijon-Lumbreras
    Patricia, Monzo-Gallo
    Francesco, Aiello Tommaso
    Antonio, Gallardo-Pizarro
    Emmanuelle, Gras
    Pedro, Puerta-Alcalde
    Espasa, Mateu
    Carmen, Martinez
    Andrea, Rivero
    Climent, Casals-Pascual
    Alex, Soriano
    Carolina, Garcia-Vidal
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 147
  • [25] Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation
    Whited, Laura
    Grove, Meagan
    Rose, Dusten
    Rhodes, Nathaniel J.
    Scheetz, Marc H.
    O'Donnell, J. Nicholas
    Neeb, Jessica
    Thoele, Kelli
    Jones, David R.
    Lowe, Christopher
    Moore, Dawn
    Kiel, Patrick J.
    PHARMACOTHERAPY, 2016, 36 (09): : 1003 - 1010
  • [26] Remote Patient Monitoring to Transform Management of Febrile Neutropenia in Cancer Patients
    Pritchett, Joshua C.
    Paludo, Jonas C.
    Borah, Bijan J.
    Haddad, Tufia C.
    NEJM CATALYST INNOVATIONS IN CARE DELIVERY, 2024, 5 (04):
  • [27] Prospective study of pattern of fungal infection in pediatric hematolymphoid malignancies with high risk febrile neutropenia
    Karanth, Naravan
    Nair, Reena
    Kelkar, Rohini
    Karanth, Pranjali
    Gawade, Yogita
    Verma, Amrita
    Mathure, Charusheela
    Parikh, Purvish
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 512 - 512
  • [28] Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies
    Huang, Huiqiang
    Li, Zengjun
    Cheng, Gang
    Yan, Gao
    Yao, Zhihua
    Zhang, Guifang
    Wang, Xiaoguang
    Han, Zhengxiang
    Chen, Yong
    Yan, Haijiao
    Zheng, Weie
    Yan, Jun
    Gu, Yulan
    Ren, Zhangxia
    Zhao, Rusen
    Zhang, Ningling
    Ma, Jun
    BLOOD, 2021, 138
  • [29] The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
    Cherif, H
    Johansson, E
    Björkholm, M
    Kalin, M
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 215 - 222
  • [30] CURRENT APPROACH TO TREATMENT OF FEBRILE NEUTROPENIA IN HEMATOLOGIC PATIENTS
    Busca, A.
    De Rosa, F. G.
    HAEMATOLOGICA, 2015, 100 : 187 - 189